Literature DB >> 23591445

Dialysis: A step towards making online haemodiafiltration a gold standard.

Francesco Locatelli1, Walter H Hörl.   

Abstract

Mesh:

Year:  2013        PMID: 23591445     DOI: 10.1038/nrneph.2013.75

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

Review 1.  Efficacy of haemodiafiltration.

Authors:  V Wizemann; M Külz; F Techert; B Nederlof
Journal:  Nephrol Dial Transplant       Date:  2001       Impact factor: 5.992

2.  Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes.

Authors:  Muriel P C Grooteman; Marinus A van den Dorpel; Michiel L Bots; E Lars Penne; Neelke C van der Weerd; Albert H A Mazairac; Claire H den Hoedt; Ingeborg van der Tweel; Renée Lévesque; Menso J Nubé; Piet M ter Wee; Peter J Blankestijn
Journal:  J Am Soc Nephrol       Date:  2012-04-26       Impact factor: 10.121

3.  Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study.

Authors:  Ercan Ok; Gulay Asci; Huseyin Toz; Ebru Sevinc Ok; Fatih Kircelli; Mumtaz Yilmaz; Ender Hur; Meltem Sezis Demirci; Cenk Demirci; Soner Duman; Ali Basci; Siddig Momin Adam; Ismet Onder Isik; Murat Zengin; Gultekin Suleymanlar; Mehmet Emin Yilmaz; Mehmet Ozkahya
Journal:  Nephrol Dial Transplant       Date:  2012-12-09       Impact factor: 5.992

4.  Online haemodiafiltration: definition, dose quantification and safety revisited.

Authors:  James E Tattersall; Richard A Ward
Journal:  Nephrol Dial Transplant       Date:  2013-01-22       Impact factor: 5.992

5.  High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients.

Authors:  Francisco Maduell; Francesc Moreso; Mercedes Pons; Rosa Ramos; Josep Mora-Macià; Jordi Carreras; Jordi Soler; Ferran Torres; Josep M Campistol; Alberto Martinez-Castelao
Journal:  J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 10.121

Review 6.  Dialysis adequacy today: a European perspective.

Authors:  Francesco Locatelli; Bernard Canaud
Journal:  Nephrol Dial Transplant       Date:  2012-06-28       Impact factor: 5.992

7.  Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS.

Authors:  B Canaud; J L Bragg-Gresham; M R Marshall; S Desmeules; B W Gillespie; T Depner; P Klassen; F K Port
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

8.  Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD.

Authors:  Francesco Locatelli; Paolo Altieri; Simeone Andrulli; Piergiorgio Bolasco; Giovanna Sau; Luciano A Pedrini; Carlo Basile; Salvatore David; Mariano Feriani; Giovanni Montagna; Biagio Raffaele Di Iorio; Bruno Memoli; Raffaella Cravero; Giovanni Battaglia; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 10.121

9.  Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group.

Authors:  F Locatelli; F Mastrangelo; B Redaelli; C Ronco; D Marcelli; G La Greca; G Orlandini
Journal:  Kidney Int       Date:  1996-10       Impact factor: 10.612

10.  Effect of membrane permeability on survival of hemodialysis patients.

Authors:  Francesco Locatelli; Alejandro Martin-Malo; Thierry Hannedouche; Alfredo Loureiro; Menelaos Papadimitriou; Volker Wizemann; Stefan H Jacobson; Stanislaw Czekalski; Claudio Ronco; Raymond Vanholder
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

  10 in total
  1 in total

1.  Mortality risk in patients on hemodiafiltration versus hemodialysis: a 'real-world' comparison from the DOPPS.

Authors:  Francesco Locatelli; Angelo Karaboyas; Ronald L Pisoni; Bruce M Robinson; Joan Fort; Raymond Vanholder; Hugh C Rayner; Werner Kleophas; Stefan H Jacobson; Christian Combe; Friedrich K Port; Francesca Tentori
Journal:  Nephrol Dial Transplant       Date:  2018-04-01       Impact factor: 5.992

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.